The first Genmab trade was made in Q3 2019.
Since then Andreas Halvorsen bought shares one more times and sold shares on five occasions. The investor completely sold their stake between Q2 2020 and Q1 2021.
Avg closing price
Price range
Sold -378 Thousand shares
Q1 2021
Avg closing price
$37.61
Price range
$30.92
-
$44.40
Sold 0.2% shares (-842 shares)
Q4 2020
Avg closing price
$37.38
Price range
$33.66
-
$40.76
Sold 34.2% shares (-197 Thousand shares)
Q3 2020
Avg closing price
$36.16
Price range
$33.07
-
$38.68
Sold 31.6% shares (-266 Thousand shares)
Q2 2020
Avg closing price
$27.25
Price range
$20.05
-
$33.89
Increased shares by 43.7% (+256 Thousand shares)
Q1 2020